CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
Clinical trial NCT05291156 · UNKNOWN
Trial details
- NCT number
- NCT05291156
- Sponsor
- University of Campania Luigi Vanvitelli
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-21
- Primary completion
- 2025-07-01
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.